StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Xencor price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Xencor's price to sales ratio was 28.3× on Nov 11, 2026, against 8.2× a year earlier. Over the last 5 years it ranged from 3.9× to 28.3×, with a median of 7.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202628.3×+21.0
2025Dec 31, 20257.3×−7.5
2024Dec 31, 202414.8×+5.9
2023Dec 29, 20238.9×+3.6
2022Dec 30, 20225.2×−9.2
2021Dec 31, 202114.4×−15.3
2020Dec 31, 202029.7×+17.8
2019Dec 31, 201911.8×−17.7
2018Apr 30, 201829.5×–

More Xencor figures

See a number that looks wrong?